Our
Services

Device Access Europe supports medical device manufacturers and distributors with all aspects of reimbursement from coding analysis to development and implementation of robust local and national market access strategies.
Understanding the current situation
Coding and reimbursement analysis

Does your technology fall within an existing reimbursement code facilitating immediate reimbursement and if so, how much money is available to treat each patient?

Patient pathway analysis

What is the current patient pathway and how many patients could benefit from your technology in country specific reimbursement systems?

Reimbursement strategy

How can you optimise the cost of your technology through different reimbursement pathways?

Local market access
Hospital cost model

What is the overall value of your technology to the local healthcare provider?

Development of local hospital
value dossiers

What is the current patient pathway and how many patients could benefit from your technology in country specific reimbursement systems?

National market access
Preparation and submission of
Health Technology Appraisal (HTA)
application & additional
reimbursement pathways

To review available pathways for your technology, view our reimbursement decision trees.

Systematic literature
& guideline reviews
Gap analysis in your clinical
& economic data
Development of health economic
model & publication
Expert advisory group workshops and
KOL interviews
IGES Group
Device Access Europe is part of the IGES Group which is an independent provider of research and consulting services for the life sciences industry and offers additional services to support the development and implementation of clinical trials and regulatory advice during the product life cycle.
Contact us